Iterum Therapeutics (ITRM) Stock Chart & Stock Price History → AI finds its first serious application (From Wall Street Star) (Ad) Free ITRM Stock Alerts $1.48 -0.05 (-3.27%) (As of 11:08 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Iterum Therapeutics Stock Price Performance5 Day Performance-9.47%1 Month Performance-6.71%3 Month Performance-0.65%6 Month Performance+109.59%Year-To-Date Performance-22.34%1 Year Performance+31.90% Receive ITRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. ITRM Stock Chart for Wednesday, May, 1, 2024 ITRM Chart by TradingView Iterum Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2024$1.54$1.53-0.65%$1.64$1.50157,708 shs$25.14 million04/29/2024$1.67$1.54-7.78%$1.75$1.48510,757 shs$25.30 million04/26/2024$1.57$1.69+7.64%$1.72$1.52106,274 shs$27.77 million04/25/2024$1.55$1.57+1.29%$1.57$1.5050,845 shs$25.80 million04/24/2024$1.58$1.55-1.90%$1.60$1.5035,939 shs$25.47 million04/23/2024$1.55$1.58+1.94%$1.60$1.5536,278 shs$25.96 million Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/22/2024$1.43$1.55+8.39%$1.60$1.46197,643 shs$25.46 million04/19/2024$1.43$1.43$1.51$1.4259,817 shs$23.50 million04/18/2024$1.44$1.43-0.69%$1.46$1.4356,731 shs$23.50 million04/17/2024$1.45$1.44-0.69%$1.50$1.4275,335 shs$23.66 million04/16/2024$1.54$1.45-5.84%$1.55$1.45168,662 shs$23.82 million04/15/2024$1.58$1.54-2.53%$1.63$1.5098,692 shs$25.30 million04/12/2024$1.62$1.58-2.47%$1.65$1.5882,978 shs$25.96 million04/11/2024$1.64$1.62-1.22%$1.70$1.6042,966 shs$26.62 million04/10/2024$1.67$1.64-1.80%$1.74$1.61136,157 shs$26.95 million04/09/2024$1.70$1.67-1.76%$1.76$1.65119,638 shs$27.44 million04/08/2024$1.76$1.70-3.41%$1.82$1.65187,688 shs$27.93 million04/05/2024$1.87$1.76-5.88%$1.85$1.72215,910 shs$28.92 million04/04/2024$1.55$1.87+20.65%$1.93$1.59749,402 shs$30.72 million04/03/2024$1.60$1.55-3.13%$1.60$1.5388,134 shs$20.82 million04/02/2024$1.64$1.60-2.44%$1.65$1.55131,141 shs$21.50 million04/01/2024$1.54$1.64+6.49%$1.66$1.55158,512 shs$22.04 million03/29/2024$1.54$1.54$1.67$1.49228,461 shs$20.70 million03/28/2024$1.59$1.54-3.14%$1.67$1.49225,397 shs$20.70 million03/27/2024$1.56$1.59+1.92%$1.61$1.54144,483 shs$21.37 million03/26/2024$1.55$1.56+0.65%$1.58$1.5275,185 shs$20.97 million03/25/2024$1.60$1.55-3.13%$1.63$1.5499,254 shs$20.83 million03/22/2024$1.58$1.60+1.27%$1.65$1.54115,222 shs$21.50 million03/21/2024$1.58$1.58$1.61$1.5578,600 shs$21.24 million03/20/2024$1.65$1.58-4.24%$1.67$1.57226,902 shs$21.24 million03/19/2024$1.63$1.65+1.23%$1.67$1.62175,977 shs$22.18 million03/18/2024$1.46$1.63+11.64%$1.66$1.55266,759 shs$21.91 million03/15/2024$1.45$1.46+0.69%$1.53$1.4179,489 shs$19.62 million03/14/2024$1.52$1.45-4.61%$1.50$1.4351,599 shs$19.48 million03/13/2024$1.67$1.52-8.98%$1.68$1.43246,753 shs$20.42 million03/12/2024$1.62$1.67+3.09%$1.69$1.56135,877 shs$22.45 million03/11/2024$1.55$1.62+4.52%$1.69$1.54299,775 shs$21.77 million03/08/2024$1.51$1.55+2.65%$1.59$1.51164,650 shs$20.83 million03/07/2024$1.49$1.51+1.34%$1.61$1.49402,778 shs$20.29 million03/06/2024$1.27$1.49+17.79%$1.57$1.37769,195 shs$20.03 millionREAD THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details.03/05/2024$1.24$1.27+2.02%$1.33$1.25152,729 shs$17.00 million03/04/2024$1.30$1.24-4.62%$1.31$1.23130,278 shs$16.66 million03/01/2024$1.24$1.30+4.84%$1.31$1.22173,235 shs$17.47 million02/29/2024$1.28$1.24-3.13%$1.30$1.24148,411 shs$16.67 million02/28/2024$1.32$1.28-3.03%$1.33$1.26102,404 shs$17.20 million02/27/2024$1.28$1.32+3.13%$1.35$1.24217,082 shs$17.74 million02/26/2024$1.27$1.28+0.79%$1.32$1.23161,317 shs$17.20 million02/23/2024$1.35$1.27-5.93%$1.39$1.22435,094 shs$17.07 million02/22/2024$1.44$1.35-6.25%$1.47$1.35246,501 shs$18.14 million02/21/2024$1.47$1.44-2.04%$1.49$1.43140,206 shs$19.35 million02/20/2024$1.48$1.47-0.68%$1.50$1.4598,207 shs$19.76 million02/19/2024$1.48$1.48$1.54$1.48179,200 shs$19.89 million02/16/2024$1.50$1.48-1.33%$1.54$1.48178,940 shs$19.89 million02/15/2024$1.48$1.50+1.35%$1.55$1.48130,364 shs$20.15 million02/14/2024$1.44$1.48+2.78%$1.51$1.44124,170 shs$19.88 million02/13/2024$1.57$1.44-8.28%$1.55$1.42334,250 shs$19.35 million02/12/2024$1.62$1.57-3.09%$1.62$1.53256,380 shs$21.10 million02/09/2024$1.59$1.62+1.89%$1.63$1.56136,507 shs$21.77 million02/08/2024$1.65$1.59-3.64%$1.65$1.52297,479 shs$21.37 million02/07/2024$1.58$1.65+4.43%$1.76$1.56887,444 shs$22.18 million02/06/2024$1.42$1.58+11.27%$1.62$1.38384,590 shs$21.24 million02/05/2024$1.57$1.42-9.55%$1.59$1.42318,446 shs$19.09 million02/02/2024$1.54$1.57+1.95%$1.63$1.46347,505 shs$21.10 million02/01/2024$1.54$1.54$1.66$1.43798,591 shs$20.70 million01/31/2024$1.58$1.54-2.53%$1.80$1.451.50 million shs$20.70 million01/30/2024$1.79$1.58-11.73%$2.34$1.5424.40 million shs$21.24 million Related Companies: DURECT Stock Price Chart Eyenovia Stock Price Chart Qilian International Holding Group Stock Price Chart Lipocine Stock Price Chart Vaxxinity Stock Price Chart Sol-Gel Technologies Stock Price Chart Forte Biosciences Stock Price Chart Unity Biotechnology Stock Price Chart Sensei Biotherapeutics Stock Price Chart Acasti Pharma Stock Price Chart Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ITRM) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New A.I. Device is About to Shock the WorldInvestorPlaceAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPubThe biggest energy story ever? Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersYour bank is lying to you.MyBankTrackerBiden to Launch “FedNOW” [Move Your Money Now]Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.